Trending Stocks : Ariad Pharmaceuticals (NASDAQ:ARIA), Checkpoint (NYSE:CKP), Computer Sciences (NYSE:CSC), Seattle Genetics Inc. (NASDAQ:SGEN), Infoblox Inc. (NYSE:BLOX)

US specialty pharma firm Ariad Pharmaceuticals (NASDAQ:ARIA) has granted Israel’s Medison Pharma exclusive rights to commercialize Iclusig (ponatinib) in Israel for patients with Philadelphia-positive (Ph+) leukemias. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is -12.09%. On last trading day company shares ended up $5.38. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) distance from 50-day simple moving average (SMA50) is -12.94%.

Checkpoint Systems, Inc. (NYSE:CKP) today reported financial results for the second quarter ended June 29, 2014. Net revenues from continuing operations in the second quarter of 2014 decreased 0.8%, to $170.9 million from $172.3 million in the second quarter of 2013. Foreign currency translation effects resulted in a $1.0 million or 0.6% increase in net revenues. During the quarter, gross profit margins were 42.4% compared with 40.6% in the 2013 second quarter. Checkpoint Systems Inc. (NYSE:CKP) shares advanced 5.16% in last trading session and ended the day at $14.05. CKP Gross Margin is 40.40% and its return on assets is -1.50%. Checkpoint Systems Inc. (NYSE:CKP) quarterly performance is 9.68%.

Computer Sciences Corporation (NYSE:CSC) is set to report first-quarter 2015 results on Aug 7. Last quarter, the company posted a positive earnings surprise of 5.8%. Moreover, it is worth noting that Computer Sciences has outperformed the Zacks Consensus Estimate in all the four preceding quarters with an average positive surprise of 19.9%. On 06 August, Computer Sciences Corporation (NYSE:CSC) shares moved down -0.42% and was closed at $62.10. CSC EPS growth in last 5 year was -11.30%. Computer Sciences Corporation (NYSE:CSC) year to date (YTD) performance is 11.89%.

This week, Seattle Genetics, Inc.’s (NASDAQ:SGEN) ratings are up from a C last week to a B. Seattle Genetics is a clinical-stage biotechnology company that is focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. Seattle Genetics Inc. (NASDAQ:SGEN) ended the last trading day at $38.75. Company weekly volatility is calculated as 5.68%and price to cash ratio as 13.43. Seattle Genetics Inc. (NASDAQ:SGEN) showed a weekly performance of 7.97%.

Infoblox Inc. (NYSE:BLOX), the network control company, today announced that its Infoblox Automation Solutions Architect (IASA) program has trained and certified more than 900 pre-sales engineers worldwide, less than two and a half years after the program’s launch. Infoblox Inc. (NYSE:BLOX) shares moved down -1.05% in last trading session and ended the day on $12.20. BLOX Gross Margin is 77.90% and its return on assets is -3.70%. Infoblox Inc. (NYSE:BLOX) quarterly performance is -31.46%.